Solutions to the Challenges of Phase I and FIM Studies in Today’s World

This 90-minute webinar will help you identify the challenges in Phase I and FIM studies and present solutions on how to overcome these challenges.

Why Should You Attend:

As need for more aggressive drug development that still ensures the safety of the subjects and the drug itself becomes more and more important, the challenges of those individuals responsible for the Phase I activities increase exponentially. To not meet these challenges has consequences.

Who Will Benefit:

This Webinar will provide invaluable assistance to investigators and their staff in the regulatory / legal
... see full description»

This 90-minute webinar will help you identify the challenges in Phase I and FIM studies and present solutions on how to overcome these challenges.

Why Should You Attend:

As need for more aggressive drug development that still ensures the safety of the subjects and the drug itself becomes more and more important, the challenges of those individuals responsible for the Phase I activities increase exponentially. To not meet these challenges has consequences.

Who Will Benefit:

This Webinar will provide invaluable assistance to investigators and their staff in the regulatory / legal responsibilities and also the ethical considerations in pharmaceutical product (Drug or device) research involving human subjects.

Those benefiting the most would be:

Holders of the IND for new products
Principal Investigators and sub investigators
Clinical Research Scientists (PKs, Biostatisticians, ...)
Safety Nurses
Clinical Research Associates (CRAs) and Coordinators (CRCs)
Recruiting staff